Circulating miRNAs as biomarker in cancer - CEA - Commissariat à l’énergie atomique et aux énergies alternatives Accéder directement au contenu
Article Dans Une Revue Recent Results in Cancer Research Année : 2020

Circulating miRNAs as biomarker in cancer

Résumé

Deregulation of microRNA expression has been shown to play an important role in human malignancies. The identification of circulating-free miRNAs in biofluids a decade ago led to great enthusiasm and motivation to develop non-invasive tests based on the expression of these small non-coding RNAs. Herein, we review the progress within the field of research for identifying circulating miRNA cancer biomarkers and discuss the advantages and challenges associated with this. We also discuss the methodological and analytical variables, which may influence the final miRNA quantification and the importance of standardizing pre-analytical, analytical, and post-analytical processes in order to enable a successful translation of the results from basic research into the clinics.
Fichier non déposé

Dates et versions

cea-04419419 , version 1 (26-01-2024)

Identifiants

Citer

Gitte Brinch Andersen, Jörg Tost. Circulating miRNAs as biomarker in cancer. Recent Results in Cancer Research, 2020, 215, pp.277-298. ⟨10.1007/978-3-030-26439-0_15⟩. ⟨cea-04419419⟩
4 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More